logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation

New Stock Margin Statistics | November 10th

date
18:38 10/11/2023
avatar
GMT Eight
Shanxi Installation (02520) is currently in the process of going public.
Shanxi Installation (02520) is currently in the process of IPO. As of November 10th, Futu, Hui Li and other securities firms have collectively lent out 0.05193 billion Hong Kong dollars to Shanxi Installation through margin financing, but the subscription is not sufficient.
Related Articles
Zijin Longking (600388.SH) plans to invest approximately US$26.62 million to build the Phase III solar-plus-storage project for the Aurora Gold Mine processing plant in Guyana.
China Stock
Ningbo Tianyi Medical Appliance (301097.SZ) products obtain EU MDR certification.
China Stock
Guangdong Taienkang Pharmaceutical (301263.SZ) subsidiary obtains preliminary analysis results from Phase IIa clinical trial for CKBA cream rosacea indication.
Zijin Longking (600388.SH) plans to invest approximately US$26.62 million to build the Phase III solar-plus-storage project for the Aurora Gold Mine processing plant in Guyana.
Ningbo Tianyi Medical Appliance (301097.SZ) products obtain EU MDR certification.
China Stock
Guangdong Taienkang Pharmaceutical (301263.SZ) subsidiary obtains preliminary analysis results from Phase IIa clinical trial for CKBA cream rosacea indication.
China Stock
RECOMMEND
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
icon
22/09/2026
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.